Medicine

When general population discuss modern medicine, precision plays one of the most important roles and human lives are literally dependent on it. Hence, any researches pertaining to medicine are required to meet the top standards. The issue today is that any outcomes of researches can be shared online and used as a reference without being precisely checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been established back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality indicator. That assists both readers and authors to quality-check publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website demonstrates a full publications list with corresponding scores higher than

A promising new treatment option for the coronavirus was studied using a COVID-19 pseudovirus approach to observe its immune response to MEK inhibitors. 3D Illustration of COVID-19 3D Illustration of Coronavirus COVID-19 As researchers around the world are in the midst of searching for treatment options capable of combatting the COVID-19 virus, a single solution will not be effective for everyone—in both a logistical and biological sense. To produce different treatment options for populations of varying age and immune system health, numerous avenues are currently being explored. One potential treatment, studied by a coalition of researchers from Brown University, the Fox Chase Cancer Center, and Verastem Oncology, used a COVID-19 pseudovirus approach to demonstrate immune response to MEK inhibitors in a level 2 biosafe environment. The paper detailing this study has been published at Oncotarget.com. oncotarget breakthrough “For the current study, we have developed a pseudotyped SAR

When general population discuss today’s medicine, accuracy plays one of the most significant roles and people’s lives are literally dependent on it. Hence, any researches related to medicine are necessary to meet the highest standards. The problem today is that any outcomes of researches can be published online and used as a reference without being precisely checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this challenge and tried to develop an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The main principle of this journal is based on Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with corresponding scores above 100 as well a

For patients with basal cell bladder cancer, researchers in this study identify MEK inhibitors as a viable therapeutic option. Onco Youtube 3d Illustration – Bladder cancer cell The Trending with Impact series highlights publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news and articles about the latest trending publications here and at Oncotarget.com. — Facebook Oncotarget “Basal bladder cancer is frequently clinically aggressive and has the worst overall prognosis [3], and thus, additional therapeutic options for these tumors would be highly clinically relevant.” Oncotarget’s In this paper published by Oncotarget, researchers from the University of Michigan conducted a study emphasizing the importance of 3D culture screenings versus 2D, and the use of MEK inhibitors to target basal cell bladder cancer. This paper concludes that basal cell bladder cancer cel

When general population mention today’s medicine, accuracy plays one of the most crucial roles and human lives are directly dependent on it. Likewise, any researches pertaining to medicine are required to meet the top standards. The issue nowadays is that any outcomes of researches can be published online and used as a reference without being thoroughly checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and attempted to develop an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality indicator. That assists both readers and authors to quality-check publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with respective scores higher t

When public refer to today’s medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Likewise, any researches pertaining to medicine are necessary to meet the highest standards. The issue nowadays is that any recommendations of researches can be published online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this problem and decided to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is related to Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a complete publications list with corresponding scores above 100 as

Researchers perform a phase three subgroup analysis study demonstrating positive results in patients with HPV-negative oropharyngeal cancers due to the addition of weekly nimotuzumab doses while receiving cisplatin and radiation treatment. Hospital This image depicts the nasopharynx, pharynx, and the oropharynx. This image illustrates the nasopharynx, pharynx, and the oropharynx. The Trending with Impact series highlights Oncotarget publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news and articles about the latest trending publications here, and at Oncotarget.com. Oncotarget’s Listen to an audio version of this article Each year, oral cancer accounts for around 53,000 new patient diagnoses in the United States. However, the highest number of cases of oral cancer in the world are found in India (primarily due to tobacco use)—and researchers say this n

When general population speak of modern medicine, precision plays one of the most crucial roles and people’s lives are directly dependent on it. Hence, any researches pertaining to medicine are required to comply with the top standards. The issue nowadays is that any conclusions of researches can be shared online and used as a reference without being thoroughly verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and tried to generate an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been founded back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality measure. That helps both readers and authors to verify publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with corresponding scores higher than 10

Drug pricing is a big issue in the news, and there is continued controversy surrounding the major differences in patented cancer drug prices around the world. However, the patterns of affordability of these drugs are poorly understood. And although cancer care is undergoing a revolution with the arrival of new therapies such as immunotherapy, monoclonal antibodies, and targeted therapy, prices for cancer drugs vary widely. “Oncotarget” A recent study in Oncotarget, 2017, Vol. 8, Issue 42, by Jonathon Clark, Daniel A. Goldstein and others entitled “A global comparison of the cost of patented cancer drugs in relation to global differences in wealth” compared patterns of affordability of cancer drugs in Australia, China, India, Israel, South Africa, the United Kingdom, and the United States to assess whether affordability corresponded to other economic indicators. The researchers considered many factors in determining patterns of affordability, including: Oncotarget International diffe

When public discuss today’s medicine, precision plays one of the most crucial roles and human lives are literally dependent on it. Hereby, any researches pertaining to medicine are necessary to comply with the top standards. The issue today is that any conclusions of researches can be published online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this problem and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been established back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality indicator. That allows both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with corresponding scores above 100 as well a

When people discuss today’s medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Hereby, any researches related to medicine are necessary to comply with the top standards. The issue nowadays is that any recommendations of researches can be published online and used as a reference without being thoroughly checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality measure. That assists both readers and authors to validate publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with respective scores higher than 100 as

There are more than 800,000 active podcasts available for listening today, and that number is projected to continue to rise as starting a podcast has become easier than ever before. Obviously, with this many podcasts to choose from, it’s becoming very difficult for podcast listeners to weed out quality listens from the podcasts that aren’t worth their time. In order to help listeners find the best podcast based on their interests, the cloud-based podcast app player.fm recently published its recent “Best-of lists” and named the open-access biomedical journal Oncotarget’s podcast in the top-ten in a list of “50 open-access podcasts for 2020”. The honor comes from the Journals’ incredible reporting and coverage on cancer research. Chicago hospital Houston hospital Phoenix hospital The Oncotarget podcast show has been informing listeners on the latest news from scientists since the fall of 2016. Past podcasts have included end-to-end readings of published papers as well as press rel

When people mention today’s medicine, accuracy plays one of the most crucial roles and human lives are directly dependent on it. Likewise, any researches related to medicine are necessary to comply with the highest standards. The challenge today is that any conclusions of researches can be shared online and used as a reference without being adequately verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality indicator. That helps both readers and authors to verify publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with respective scores higher than 100 as well as repo

In this study, researchers performed the first comprehensive analysis of the current landscape of clinical trials for pancreatic cancer to better understand the near future of potential new therapies. 3D illustration of Pancreas - part of digestive The vast scope of studies currently underway around the world sometimes makes it difficult to determine the current state of research in a particular field. Researchers based out of Cleveland, Ohio, and Charlotte, North Carolina, found this to be especially true when it comes to pancreatic cancer research. Published in Oncotarget, these researchers authored a paper meticulously detailing the current state of research in pancreatic ductal adenocarcinoma (PDAC). Chicago hospital Houston hospital Phoenix hospital Pancreatic Cancer Research Funding The National Institutes of Health (NIH) allocates somewhere around $6 billion annually to fund cancer research and, of these funds, more than $100 million is dedicated solely to the study of p

When general population mention contemporary medicine, accuracy plays one of the most significant roles and human lives are directly dependent on it. Hence, any researches related to medicine are required to comply with the highest standards. The issue nowadays is that any recommendations of researches can be published online and used as a reference without being properly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and decided to come up with an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality measure. That assists both readers and authors to verify publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with respective score

When people discuss modern medicine, accuracy plays one of the most important roles and people’s lives are directly dependent on it. Hence, any researches related to medicine are required to comply with the highest standards. The issue today is that any conclusions of researches can be published online and used as a reference without being precisely checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and decided to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality indicator. That helps both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with respective scores higher than 100 as well as repo

A team of US researchers sought to halt tumor growth in breast cancer by targeting breast cancer cell metabolism in the mitochondria through the use of an adenosine triphosphate (ATP) synthesis inhibitor. Figure 3: CADD522 treatment suppresses the levels of ATP Figure 3: CADD522 treatment suppresses the levels of ATP The Trending with Impact series highlights publications attracting higher visibility among readers around the world online, in the news, and on social media — beyond normal readership levels. Look for future science news and articles about the latest trending publications here and at Oncotarget.com. — Breast cancer has been top-of-mind for many researchers over the years. Some focus on early detection methods and others set their sights on discovering new treatment options — both are crucial for patient survival. The innumerable potential mechanisms researchers may target using countless variations of therapeutic treatments for breast cancer is vast, and, the nature of

When public refer to contemporary medicine, accuracy plays one of the most important roles and human lives are literally dependent on it. Hence, any researches related to medicine are required to meet the highest standards. The challenge today is that any outcomes of researches can be shared online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this challenge and decided to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is related to Altmetric scores that are used as a quality indicator. That allows both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with respective scores higher than 100 as well as r

In an effort to learn more about dementia, researchers evaluated 178 elderly Brazilian participants in a study on estrogen receptor polymorphisms. Amyloid plaques forming between neurons. Beta-amyloid protein disrupting nerve cells function in a brain with Alzheimer's disease Amyloid plaques forming between neurons. Beta-amyloid protein disrupting nerve cells function in a brain with Alzheimer’s disease Listen to an audio version of this article Dementia is used as a general term to describe the age-related decline in mental capabilities that are severe enough to interfere with day-to-day activities. This disorder is multifactorial and stems from genetic, metabolic, and environmental interactions. In the elderly, Alzheimer’s disease is the most common cause of dementia. As we continue to live longer, statistics have shown that the world’s elderly population is quickly increasing. Becoming elderly often coincides with a change in lifestyle, occupation, and income—which can contrib

When general population refer to modern medicine, accuracy plays one of the most important roles and human lives are literally dependent on it. Hence, any researches related to medicine are required to meet the top standards. The issue nowadays is that any results of researches can be shared online and used as a reference without being properly checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this issue and attempted to generate an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been founded back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality measure. That allows both readers and authors to verify publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with corresponding scores higher than 100 as well as repor